Nalaganje...
Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma
BACKGROUND: The epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) have been implicated as therapeutic targets for head and neck squamous cell carcinoma (HNSCC). Vandetanib is a small-molecule tyrosine kinase inhibitor (TKI) with dual specificity for EGFR...
Shranjeno v:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3675227/ https://ncbi.nlm.nih.gov/pubmed/22307735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.21917 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|